Identification of a new protective antigen of Bordetella pertussis

Vaccine

Volumn 29, Issue 47, 2011, Pages 8731-8739

  Alvarez Hayes, Jimena ^a   Erben, Esteban ^b   Lamberti, Yanina ^a   Ayala, Miguel ^c   Maschi, Fabricio ^c   Carbone, Cecilia ^c   Gatti, Blanca ^d   Parisi, Gustavo ^e   Rodriguez, Maria Eugenia ^a  

^a Universidad Nacional de La Plata   (Argentina)

^b INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

^c UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^d Hospital de Ninos Sor Maria Ludovica   (Argentina)

^e UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

Bordetella pertussis; New antigen; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; GAMMA INTERFERON; GENOMIC DNA; IMMUNOGLOBULIN G; INTERLEUKIN 10; MEMBRANE PROTEIN; PROTEIN IRP1 3; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BORDETELLA PERTUSSIS; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BORDETELLA PERTUSSIS; FEMALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; NEUTROPHILS; PERTUSSIS VACCINE; PHAGOCYTOSIS; RECOMBINANT PROTEINS;

EID: 82455210756     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.07.143     Document Type: Article

References (50)

1. Mattoo S., Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005, 18(2):326-382.
2. Wood N., McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatr Respir Rev 2008, 9(3):201-211.
3. Edwards K.M., Meade B.D., Decker M.D., Reed G.F., Rennels M.B., Steinhoff M.C., et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 1995, 96(3 Pt 2):548-557.
4. Gustafsson L., Hallander H.O., Olin P., Reizenstein E., Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996, 334(6):349-355.
5. Guris D., Strebel P.M., Bardenheier B., Brennan M., Tachdjian R., Finch E., et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999, 28(6):1230-1237.
6. Hellenbrand W., Beier D., Jensen E., Littmann M., Meyer C., Oppermann H., et al. The epidemiology of pertussis in Germany: past and present. BMC Infect Dis 2009, 9:22.
7. de Melker H.E., Schellekens J.F., Neppelenbroek S.E., Mooi F.R., Rumke H.C., Conyn-van Spaendonck M.A. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis 2000, 6(4):348-357.
8. Uhl M.A., Miller J.F. Autophosphorylation and phosphotransfer in the Bordetella pertussis BvgAS signal transduction cascade. Proc Natl Acad Sci USA 1994, 91(3):1163-1167.
9. Weiss A.A., Hewlett E.L., Myers G.A., Falkow S. Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun 1983, 42(1):33-41.
10. Vergara-Irigaray N., Chavarri-Martinez A., Rodriguez-Cuesta J., Miller J.F., Cotter P.A., Martinez de Tejada G. Evaluation of the role of the Bvg intermediate phase in Bordetella pertussis during experimental respiratory infection. Infect Immun 2005, 73(2):748-760.
11. Bouchez V., Brun D., Cantinelli T., Dore G., Njamkepo E., Guiso N. First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin. Vaccine 2009, 27(43):6034-6041.
12. Guerinot M.L. Microbial iron transport. Annu Rev Microbiol 1994, 48:743-772.
13. Vidakovics M.L., Paba J., Lamberti Y., Ricart C.A., de Sousa M.V., Rodriguez M.E. Profiling the Bordetella pertussis proteome during iron starvation. J Proteome Res 2007, 6(7):2518-2528.
14. Thompson J.D., Higgins D.G., Gibson T.J., Clustal W. improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22(22):4673-4680.
15. Soding J. Protein homology detection by HMM-HMM comparison. Bioinformatics 2005, 21(7):951-960.
16. Jaroszewski L., Rychlewski L., Li Z., Li W., Godzik A. FFAS03: a server for profile-profile sequence alignments. Nucleic Acids Res 2005, 33:W284-W288. Web Server issue.
17. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993, 234(3):779-815.
18. Sippl M.J. Recognition of errors in three-dimensional structures of proteins. Proteins 1993, 17(4):355-362.
19. Sonnhammer E.L., von Heijne G., Krogh A. A hidden Markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Syst Mol Biol 1998, 6:175-182.
20. Cserzo M., Wallin E., Simon I., von Heijne G., Elofsson A. Prediction of transmembrane alpha-helices in prokaryotic membrane proteins: the dense alignment surface method. Protein Eng 1997, 10(6):673-676.
21. Relman D.A., Domenighini M., Tuomanen E., Rappuoli R., Falkow S. Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc Natl Acad Sci USA 1989, 86(8):2637-2641.
22. Weingart C.L., Broitman-Maduro G., Dean G., Newman S., Peppler M., Weiss A.A. Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun 1999, 67(8):4264-4267.
23. Schwyn B., Neilands J.B. Universal chemical assay for the detection and determination of siderophores. Anal Biochem 1987, 160(1):47-56.
24. Nagel J., de Graaf S., Schijf-Evers D. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels. Dev Biol Stand 1985, 61:325-330.
25. Rodriguez M.E., Hellwig S.M., Hozbor D.F., Leusen J., van der Pol W.L., van de Winkel J.G. Fc receptor-mediated immunity against Bordetella pertussis. J Immunol 2001, 167(11):6545-6551.
26. Kirimanjeswara G.S., Agosto L.M., Kennett M.J., Bjornstad O.N., Harvill E.T. Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest 2005, 115(12):3594-3601.
27. Pilione M.R., Harvill E.T. The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. Infect Immun 2006, 74(2):1043-1049.
28. Lamberti Y., Perez Vidakovics M.L., van der Pol L.W., Rodriguez M.E. Cholesterol-rich domains are involved in Bordetella pertussis phagocytosis and intracellular survival in neutrophils. Microb Pathog 2008, 44(6):501-511.
29. Rodriguez M.E., Van der Pol W.L., Van de Winkel J.G. Flow cytometry-based phagocytosis assay for sensitive detection of opsonic activity of pneumococcal capsular polysaccharide antibodies in human sera. J Immunol Methods 2001, 252(1-2):33-44.
30. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979, 76(9):4530-4534.
31. Chan A.C., Doukov T.I., Scofield M., Tom-Yew S.A., Ramin A.B., Mackichan J.K., et al. Structure and function of P19, a high-affinity iron transporter of the human pathogen Campylobacter jejuni. J Mol Biol 2010, 401(4):590-594.
32. Deka R.K., Brautigam C.A., Tomson F.L., Lumpkins S.B., Tomchick D.R., Machius M., et al. Crystal structure of the Tp34 (TP0971) lipoprotein of treponema pallidum: implications of its metal-bound state and affinity for human lactoferrin. J Biol Chem 2007, 282(8):5944-5958.
33. Melton A.R., Weiss A.A. Characterization of environmental regulators of Bordetella pertussis. Infect Immun 1993, 61(3):807-815.
34. Sukumar N., Sloan G.P., Conover M.S., Love C.F., Mattoo S., Kock N.D., et al. Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines. Infect Immun 2008, 78(5):2008-2016.
35. Skerry C.M., Mahon B.P. A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model. Clin Vaccine Immunol 2011, 18(2):187-193.
36. Marr N., Oliver D.C., Laurent V., Poolman J., Denoel P., Fernandez R.C. Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model. Vaccine 2008, 26(34):4306-4311.
37. Sukumar N., Love C.F., Conover M.S., Kock N.D., Dubey P., Deora R. Active and passive immunizations with Bordetella colonization factor A protect mice against respiratory challenge with Bordetella bronchiseptica. Infect Immun 2009, 77(2):885-895.
38. Aisen P., Leibman A. Lactoferrin and transferrin: a comparative study. Biochim Biophys Acta 1972, 257(2):314-323.
39. Agiato L.A., Dyer D.W. Siderophore production and membrane alterations by Bordetella pertussis in response to iron starvation. Infect Immun 1992, 60(1):117-123.
40. Brickman T.J., Kang H.Y., Armstrong S.K. Transcriptional activation of Bordetella alcaligin siderophore genes requires the AlcR regulator with alcaligin as inducer. J Bacteriol 2001, 183(2):483-489.
41. Brickman T.J., Anderson M.T., Armstrong S.K. Bordetella iron transport and virulence. Biometals 2007, 20(3-4):303-322.
42. Peng X., Ye X., Wang S. Identification of novel immunogenic proteins of Shigella flexneri 2a by proteomic methodologies. Vaccine 2004, 22(21-22):2750-2756.
43. Vytvytska O., Nagy E., Bluggel M., Meyer H.E., Kurzbauer R., Huber L.A., et al. Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics 2002, 2(5):580-590.
44. Lamberti Y.A., Hayes J.A., Perez Vidakovics M.L., Harvill E.T., Rodriguez M.E. Intracellular trafficking of Bordetella pertussis in human macrophages. Infect Immun 2010, 78(3):907-913.
45. Guiso N., Capiau C., Carletti G., Poolman J., Hauser P. Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines. Vaccine 1999, 17(19):2366-2376.
46. Redhead K., Watkins J., Barnard A., Mills K.H. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun 1993, 61(8):3190-3198.
47. Mills K.H., Barnard A., Watkins J., Redhead K. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun 1993, 61(2):399-410.
48. Barnard A., Mahon B.P., Watkins J., Redhead K., Mills K.H. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 1996, 87(3):372-380.
49. Hellwig S.M., Rodriguez M.E., Berbers G.A., van de Winkel J.G., Mooi F.R. Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J Infect Dis 2003, 188(5):738-742.
50. Deora R., Bootsma H.J., Miller J.F., Cotter P.A. Diversity in the Bordetella virulence regulon: transcriptional control of a Bvg-intermediate phase gene. Mol Microbiol 2001, 40(3):669-683.